REFERENCES
- National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(Suppl. 2)S1–S266
- Futrakul N, Sila-asna M, Futrakul P. Therapeutic strategy towards restoration of renal function in chronic kidney disease. Asian Biomedicine. 2007; 1: 33–44
- The GISEN Group (Gruppo Italinno di Studi Epidemiologici in Nefrologia). Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997; 349: 1857–1863
- Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999; 354: 359–364
- Futrakul N, Butthep P. Altered vascular homeostasis in chronic kidney disease. Clin Hemorheol Microcirc. 2007, in press.
- Solovey A, Lin Y, Browne P, et al. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997; 337: 1584–1590
- Ong-Ajyooth L, Ong-Ajyooth S, Sirisalee K, Nilwarangkur S. Lipoproteins and lipid peroxidation abnormalities in patients with chronic renal disease. J Med Assoc Thai. 1996; 79: 505–512
- Futrakul N, Tosukhowong P, Valyapongpichit Y, Tipprukmas N, Futrakul P, Patumraj S. Oxidative stress and hemodynamic maladjustment in chronic renal disease: A therapeutic implication. Ren Fail. 2002; 24: 433–445
- Futrakul N, Panichakul T, Butthep P, Futrakul P, Jetanalin P, Patumraj S, et al. Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis. Clin Hemorheol Microcirc. 2004; 31: 267–272
- Futrakul N, Siriviriyakul P, Deekajorndej T, Futrakul P. Hemodynamic maladjustment and disease progression in nephrosis with FSGS. Ren Fail. 2004; 26: 231–236
- Futrakul P, Sitprija V, Yenrudi S, Poshyachinda M, Sensirivatana R, Watana D, et al. Glomerular endothelial dysfunction determines disease progression: A hypothesis. Am J Nephrol. 1997; 17: 533–540
- Futrakul P, Poshyachinda M, Mitrakul C. Focal sclerosing glomerulonephritis: A kinetic evaluation of hemostasis and the effect of anticoagulant therapy: A controlled study. Clin Nephrol. 1978; 10: 180–186
- Futrakul N, Sila-asna M, Futrakul P. Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomedicine. 2007; 1: 33–44